Why did Mankind Pharma acquire Bharat Serums & Vaccines for ₹13,630Cr, giving Advent International a 2.8X exit in just 4 years? 🚀
Mankind's journey from ₹5Cr in 1995 to ₹10,000Cr in 2024 is impressive, but the goal is now ₹50,000Cr in the next decade! To get there, they need higher margins and a stronger foothold in the super-specialty market.
This acquisition is their ticket to the big leagues, expanding into Women's Health, ART, Critical Care, and Emergency Medicine. With BSV's R&D across India, Germany, Ukraine, Philippines & Malaysia, the future looks promising.
What do you think of this Bharat-Mankind match? 👀
#healthtech #pharma #India #acquisition #growth #strategy #MankindPharma #BharatSerums
